European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society
Open Access
- 21 April 2006
- journal article
- guideline
- Published by Wiley in European Journal of Neurology
- Vol. 13 (4), 326-332
- https://doi.org/10.1111/j.1468-1331.2006.01278.x
Abstract
Numerous sets of diagnostic criteria have sought to define chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) and randomized trials and systematic reviews of treatment have been published. The objective is to prepare consensus guidelines on the definition, investigation and treatment of CIDP. Disease experts and a patient representative considered references retrieved from MEDLINE and Cochrane Systematic Reviews in May 2004 and prepared statements which were agreed in an iterative fashion. The Task Force agreed on good practice points to define clinical and electrophysiological diagnostic criteria for CIDP with or without concomitant diseases and investigations to be considered. The principal treatment recommendations were: (1) intravenous immunoglobulin (IVIg) or corticosteroids should be considered in sensory and motor CIDP (level B recommendation); (2) IVIg should be considered as the initial treatment in pure motor CIDP (Good Practice Point); (3) if IVIg and corticosteroids are ineffective plasma exchange (PE) should be considered (level A recommendation); (4) If the response is inadequate or the maintenance doses of the initial treatment are high, combination treatments or adding an immunosuppressant or immunomodulatory drug should be considered (Good Practice Point); (5) Symptomatic treatment and multidisciplinary management should be considered (Good Practice Point).This publication has 25 references indexed in Scilit:
- Cytotoxic drugs and interferons for chronic inflammatory demyelinating polyradiculoneuropathy.Published by Wiley ,2004
- Guidance for the preparation of neurological management guidelines by EFNS scientific task forces – revised recommendations 2004*European Journal of Neurology, 2004
- Corticosteroid use in the treatment of neuromuscular disorders: Empirical and evidence‐based dataMuscle & Nerve, 2004
- Electrodiagnostic criteria for acute and chronic inflammatory demyelinating polyradiculoneuropathyMuscle & Nerve, 2004
- Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathyAnnals of Neurology, 2001
- A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathyAnnals of Neurology, 1994
- Pure motor demyelinating neuropathy: deterioration after steroid treatment and improvement with intravenous immunoglobulin.Journal of Neurology, Neurosurgery & Psychiatry, 1994
- Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy: a double blind, placebo controlled study.Journal of Neurology, Neurosurgery & Psychiatry, 1993
- Plasma Exchange in Chronic Inflammatory Demyelinating PolyradiculoneuropathyThe New England Journal of Medicine, 1986
- Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatmentAnnals of Neurology, 1982